These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 326043

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Dependence of pharmacokinetic parameters on the body weight.
    Weiss M, Sziegoleit W, Förster W.
    Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):572-5. PubMed ID: 598952
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Drug therapy in liver diseases: problems in intensive care].
    Follath F.
    Schweiz Med Wochenschr; 1986 Apr 26; 116(17):549-52. PubMed ID: 3715434
    [Abstract] [Full Text] [Related]

  • 29. [Effect of various physiological and pathological conditions on the bioavailability of drugs].
    Danysz A, Wierzba K.
    Pol Tyg Lek; 1979 Jan 22; 34(4):141-3. PubMed ID: 432125
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effects of liver disease on drug disposition in man.
    Wilkinson GR, Schenker S.
    Biochem Pharmacol; 1976 Dec 15; 25(24):2675-81. PubMed ID: 795432
    [No Abstract] [Full Text] [Related]

  • 33. [Effects of hepato-biliary diseases on drug metabolism (author's transl)].
    Pessayre D, Allemand H, Benhamou JP.
    Nouv Presse Med; 1977 Oct 22; 6(35):3209-19. PubMed ID: 928049
    [Abstract] [Full Text] [Related]

  • 34. Effects of liver congestion on hepatic drug metabolism in the rat.
    Knodell RG, Farleigh RM, Steele NM, Bond JH.
    J Pharmacol Exp Ther; 1982 Apr 22; 221(1):52-7. PubMed ID: 7062291
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Effects of liver disease on drug pharmacokinetics].
    Su CY.
    Sheng Li Ke Xue Jin Zhan; 1983 Jul 22; 14(3):238-42. PubMed ID: 6648457
    [No Abstract] [Full Text] [Related]

  • 37. [Significance of biotransformation for the elimination of drugs. Peculiarities in childhood, in liver diseases and after enzyme induction].
    Klinger W.
    Pharm Prax; 1968 Jul 22; 5():100-3. PubMed ID: 5713889
    [No Abstract] [Full Text] [Related]

  • 38. Hepatic drug metabolizing capacity of patients of cirrhosis before and after clinico-biochemical recovery.
    Chauhan CK, Nanivadekar SA, Billimoria FR.
    Indian J Physiol Pharmacol; 1989 Jul 22; 33(1):63-6. PubMed ID: 2737749
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Comparison of pharmacokinetics of the combination trimethoprim and sulfamethoxazole in patients with liver diseases and healthy persons].
    Rieder VJ, Schwartz DE.
    Arzneimittelforschung; 1975 Apr 22; 25(4):656-66. PubMed ID: 1174084
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.